{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "October 2016: 55-year-old female presented with a cough. Chest CT showed a lesion in the upper lobe of the left lung. Diagnosis: Lung adenocarcinoma.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C34.9",
              "label": "Lung adenocarcinoma",
              "status": "active",
              "onset_date": "2016-10"
            }
          ],
          "imaging": [
            {
              "type": "Radiography",
              "body_part": "Lung",
              "modality": "CT",
              "finding": "lesion in the upper lobe of the left lung",
              "impression": "lesion in the upper lobe of the left lung",
              "date": "2016-10"
            }
          ],
          "HPI": [
            {
              "summary": "cough",
              "onset": "2016-10"
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "November 2016: Underwent right upper lobectomy with visceral pleural involvement detected. Pathology: pT2aN0M0, stage IB.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Lobectomy",
              "approach": "open",
              "date": "2016-11",
              "location": "right upper lobe",
              "outcome": "Visceral pleural involvement detected"
            }
          ],
          "diagnoses": [
            {
              "code": "T2a",
              "label": "pT2aN0M0, stage IB",
              "status": "historical",
              "onset_date": "2016-11"
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Postoperative pathology: TTF-1 (+), NapsinA (+), TG (\u2212), ALK (\u2212), ROS-1 (\u2212) invasive adenocarcinoma. Received four cycles of adjuvant chemotherapy (pemetrexed plus cisplatin).",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C2332517",
              "label": "Adenocarcinoma, Invasive",
              "status": "historical"
            }
          ],
          "procedures": [
            {
              "name": "Chemotherapy",
              "approach": "IV",
              "date": null,
              "location": null,
              "performed_by": null,
              "outcome": null
            }
          ],
          "medications": [
            {
              "drug": "C0086403",
              "dosage": null,
              "frequency": null,
              "modality": "IV",
              "start_date": null,
              "end_date": null,
              "indication": "C2332517"
            },
            {
              "drug": "C0008833",
              "dosage": null,
              "frequency": null,
              "modality": "IV",
              "start_date": null,
              "end_date": null,
              "indication": "C2332517"
            }
          ],
          "labs": [
            {
              "test": "C1297537",
              "value": "positive",
              "unit": null,
              "flag": null,
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "C3537275",
              "value": "positive",
              "unit": null,
              "flag": null,
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "C0200237",
              "value": "negative",
              "unit": null,
              "flag": null,
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "C1706244",
              "value": "negative",
              "unit": null,
              "flag": null,
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "C4073038",
              "value": "negative",
              "unit": null,
              "flag": null,
              "reference_range": null,
              "timestamp": null
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "April 2017: Follow-up contrast-enhanced CT scan showed a spinal metastasis (stage IV).",
        "clinical_data": {
          "imaging": [
            {
              "type": "Computed tomography",
              "body_part": "Spine",
              "modality": "CT",
              "finding": "Spinal metastasis",
              "date": "2017-04"
            }
          ],
          "diagnoses": [
            {
              "code": "C0242964",
              "label": "Metastasis",
              "status": "active",
              "onset_date": "2017-04"
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "MSK-IMPACT sequencing: EGFR exon 19 deletion without KRAS mutation.",
        "clinical_data": {
          "labs": [
            {
              "test": "MSK-IMPACT sequencing",
              "value": "EGFR exon 19 deletion without KRAS mutation"
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "Patient was given gefitinib (250mg/d) and achieved a stable disease state.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C1307296",
              "dosage": "250mg",
              "frequency": "daily",
              "modality": "oral",
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ],
          "diagnoses": [
            {
              "code": "C0009402",
              "label": "Disease",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "January 2018: Contrast-enhanced CT scan detected a spinal metastasis. Molecule genetic testing confirmed EGFR T790M mutation and a negative PD-L1 expression.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Computed tomography",
              "body_part": "Spine",
              "modality": "CT",
              "finding": "spinal metastasis",
              "date": "2018-01"
            }
          ],
          "diagnoses": [
            {
              "code": "T790M",
              "label": "EGFR T790M mutation",
              "status": "active",
              "onset_date": "2018-01"
            }
          ],
          "labs": [
            {
              "test": "PD-L1 expression",
              "value": "negative",
              "flag": "abnormal",
              "timestamp": "2018-01"
            }
          ]
        }
      }
    },
    {
      "id": "N8",
      "label": "Step 8",
      "customData": {
        "node_id": "H",
        "node_step_index": 7,
        "content": "Patient received Osimertinib (80 mg/d) for 12 months, after which an extensive bone metastasis was found using bone isotope scanning.",
        "clinical_data": {
          "medications": [
            {
              "drug": "Osimertinib",
              "dosage": "80 mg/d",
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ],
          "imaging": [
            {
              "type": null,
              "body_part": "bone",
              "modality": "other",
              "finding": "extensive bone metastasis",
              "impression": null,
              "date": null
            }
          ]
        }
      }
    },
    {
      "id": "N9",
      "label": "Step 9",
      "customData": {
        "node_id": "I",
        "node_step_index": 8,
        "content": "Re-biopsy of bone metastasis: Negative for EGFR-T790 mutation, positive for KRAS exon 2 (G12D, MAF:13.34%) and exon 3 (Q61H, MAF:0.43%) mutations, and EGFR exon 19 deletion (MAF:22.58%) mutation. Plasma circulating tumor DNA (ctDNA) confirmed the above results by next Generation Sequencing (NGS).",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0027051",
              "label": "Metastasis",
              "status": "active",
              "onset_date": null
            }
          ],
          "labs": [
            {
              "test": "EGFR-T790 mutation",
              "value": "Negative",
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "KRAS exon 2 (G12D, MAF:13.34%) mutation",
              "value": "Positive",
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "KRAS exon 3 (Q61H, MAF:0.43%) mutations",
              "value": "Positive",
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "EGFR exon 19 deletion (MAF:22.58%) mutation",
              "value": "Positive",
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            }
          ]
        }
      }
    },
    {
      "id": "N10",
      "label": "Step 10",
      "customData": {
        "node_id": "J",
        "node_step_index": 9,
        "content": "Patient underwent two cycles of paclitaxel (albumin-bound) plus carboplatin for six weeks, with no apparent benefits.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0030372",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C0007272",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N11",
      "label": "Step 11",
      "customData": {
        "node_id": "K",
        "node_step_index": 10,
        "content": "Patient discontinued anti-tumor treatments, including immune checkpoint inhibitors (ICIs), due to poor physical condition.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0021827",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": "C0009450"
            }
          ]
        }
      }
    },
    {
      "id": "N12",
      "label": "Step 12",
      "customData": {
        "node_id": "L",
        "node_step_index": 11,
        "content": "March 2017: 54-year-old male non-smoker diagnosed with NSCLC adenocarcinoma metastasizing to double lung, mediastinal and the cervical lymph nodes (cT3N3M1a, stage IV). Pathological biopsy revealed TTF-1 (+), NapsinA (+), CK5/6 (-), TG (\u2212), ALK (\u2212), ROS-1 (\u2212) invasive adenocarcinoma. Next generation sequencing (NGS) on tumor biopsy tissues revealed an EGFR exon 19 deletion without a KRAS mutation.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C34.9",
              "label": "Non-small cell lung cancer",
              "status": "active",
              "onset_date": "2017-03"
            },
            {
              "code": "C77.9",
              "label": "Metastatic cancer",
              "status": "active",
              "onset_date": "2017-03"
            },
            {
              "code": "85510",
              "label": "Adenocarcinoma, NOS",
              "status": "active",
              "onset_date": "2017-03"
            }
          ],
          "labs": [
            {
              "test": "TTF-1",
              "value": "positive",
              "unit": null,
              "flag": "positive",
              "reference_range": null,
              "timestamp": "2017-03"
            },
            {
              "test": "Napsin A",
              "value": "positive",
              "unit": null,
              "flag": "positive",
              "reference_range": null,
              "timestamp": "2017-03"
            },
            {
              "test": "CK5/6",
              "value": "negative",
              "unit": null,
              "flag": "negative",
              "reference_range": null,
              "timestamp": "2017-03"
            },
            {
              "test": "TG",
              "value": "negative",
              "unit": null,
              "flag": "negative",
              "reference_range": null,
              "timestamp": "2017-03"
            },
            {
              "test": "ALK",
              "value": "negative",
              "unit": null,
              "flag": "negative",
              "reference_range": null,
              "timestamp": "2017-03"
            },
            {
              "test": "ROS-1",
              "value": "negative",
              "unit": null,
              "flag": "negative",
              "reference_range": null,
              "timestamp": "2017-03"
            },
            {
              "test": "EGFR exon 19 deletion",
              "value": "positive",
              "unit": null,
              "flag": "positive",
              "reference_range": null,
              "timestamp": "2017-03"
            },
            {
              "test": "KRAS mutation",
              "value": "negative",
              "unit": null,
              "flag": "negative",
              "reference_range": null,
              "timestamp": "2017-03"
            }
          ]
        }
      }
    },
    {
      "id": "N13",
      "label": "Step 13",
      "customData": {
        "node_id": "M",
        "node_step_index": 12,
        "content": "Patient accepted gefitinib (250 mg/d) which produced a partial response in the right lung on contrasted CT.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0974679",
              "dosage": "250 mg/d",
              "frequency": null,
              "modality": "oral",
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ],
          "imaging": [
            {
              "type": "C0238534",
              "body_part": "C0024132",
              "modality": "CT",
              "finding": "partial response",
              "impression": null,
              "date": null
            }
          ]
        }
      }
    },
    {
      "id": "N14",
      "label": "Step 14",
      "customData": {
        "node_id": "N",
        "clinical_data": {}
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Progression from initial diagnosis to surgical intervention."
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Post-operative treatment and pathology results."
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Disease progression with spinal metastasis detected on follow-up imaging."
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Molecular profiling to identify targetable mutations."
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Treatment initiated with gefitinib following EGFR exon 19 deletion."
      }
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Disease progression with spinal metastasis and EGFR T790M mutation detected."
      }
    },
    {
      "from": "N7",
      "to": "N8",
      "data": {
        "edge_id": "G_to_H",
        "branch_flag": true,
        "content": "Treatment changed to Osimertinib."
      }
    },
    {
      "from": "N8",
      "to": "N9",
      "data": {
        "edge_id": "H_to_I",
        "branch_flag": true,
        "content": "Disease progression with extensive bone metastasis and re-biopsy results."
      }
    },
    {
      "from": "N9",
      "to": "N10",
      "data": {
        "edge_id": "I_to_J",
        "branch_flag": true,
        "content": "Treatment with paclitaxel and carboplatin initiated."
      }
    },
    {
      "from": "N10",
      "to": "N11",
      "data": {
        "edge_id": "J_to_K",
        "branch_flag": true,
        "content": "Discontinuation of anti-tumor treatments due to poor physical condition."
      }
    },
    {
      "from": "N11",
      "to": "N12",
      "data": {
        "edge_id": "K_to_L",
        "branch_flag": true,
        "content": "New patient case begins."
      }
    },
    {
      "from": "N12",
      "to": "N13",
      "data": {
        "edge_id": "L_to_M",
        "branch_flag": true,
        "content": "Treatment with gefitinib initiated."
      }
    },
    {
      "from": "N13",
      "to": "N14",
      "data": {
        "edge_id": "M_to_N",
        "branch_flag": true,
        "content": "No new information."
      }
    }
  ]
}